ReviewDrugs2019
Therapies Directed Against B-Cells and Downstream Effectors in Generalized Autoimmune Myasthenia Gravis: Current Status.
Grayson Beecher et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
27 papers cite it
this paperpooled ittrialcites it